A phase 1b randomised, placebo-controlled trial of nabiximols cannabinoid oromucosal spray with temozolomide in patients with recurrent glioblastoma

JOURNAL ARTICLE published 12 April 2021 in British Journal of Cancer

Authors: Chris Twelves | on behalf of the GWCA1208 study group | Michael Sabel | Daniel Checketts | Sharon Miller | Bola Tayo | Maria Jove | Lucy Brazil | Susan C. Short